By Business & Finance 
Uniphar, a healthcare services company, saw its half-year profits soar by 22.5%. Uniphar is our Company of the Month for October, in association with KPMG.
By Héloïse Chaudot
Unpihar, a health services company, has delivered a strong first-half performance for 2025, marked by solid earnings. Adjusted earnings per share rose by 21% to 9.8%, up from 8.1% a year earlier. The company attributed this increase to underlying business growth, reduced finance costs, and the benefits of its €35 million share buyback programme, through which 13.4 million shares were repurchased.
Uniphar’s EBITDA for the first six months of 2025 rose by 2.9% from €55.90m to €57.495m.
Uniphar also reported its profits before tax rose by 22.5% from €23.43m to €28.7m last year.
Chief Executive Ger Rabbette said each of Uniphar’s divisions performed in line with medium-term targets, contributing to an 8.1% rise in organic gross profit. He emphasised that the company’s focus on solving healthcare clients’ challenges, coupled with continued strategic investment, positions it well for sustained organic growth.
The board also announced an interim dividend of €0.0071 per ordinary share for the six months, representing a 6% increase on the previous year.
Looking ahead, Rabbette reaffirmed Uniphar’s confidence in achieving its €200 million EBITDA target by 2028, with at least 80% of that growth expected to be generated organically.
Company of the Month
The Company of the Month Award, in association with KPMG, recognises outstanding Irish companies. It especially acknowledges those who have made significant contributions to the business community of Ireland.
Recipients of the award are automatically put forward as candidates for the prestigious Company of the Year Award at the annual Business & Finance Awards.
Attend the Awards
The awards ceremony holds an important date for Irish and international business and political leaders, as we recognise those paving the way for business excellence on the island of Ireland and beyond. Given demand, table availability is limited. For Partnership opportunities, contact brian.kearns@businessandfinance.com.
For more information on the annual Business & Finance Awards, see www.businessandfinanceawards.com
Business & Finance, Company of the Month
Business & Finance, in association with KPMG, recognises excellence in business through the ‘Company of the Month’ award. The Company of the Month award recognises the company that best demonstrates outstanding business leadership, sustainable growth, innovative strategy, strong financial returns, and employee development.
Read More Company of the Month:
Diaceutics secures a multi-million pound contract with Partner Therapeutics
